| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/14/2009 | US20090124681 Beta-lactone compounds |
| 05/14/2009 | US20090124667 Novel Dual-Use Peptidase Inhibitors as Prodrugs for a Therapy of Inflammatory and Other Diseases |
| 05/14/2009 | US20090124635 Chemical compounds |
| 05/14/2009 | US20090124605 Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors |
| 05/14/2009 | US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 05/14/2009 | US20090124586 Aqueous-based pharmaceutical composition |
| 05/14/2009 | US20090124564 Compositions and methods for regulating apoptosis |
| 05/14/2009 | US20090124553 Suppression of inflammation associated with transplantation using an epsilon PKC inhibitor |
| 05/14/2009 | US20090124549 administering to a patient infected with mycobacterium tuberculosis, a therapeutically effective amount of an isolated polypeptide ( a polypeptide covalently linked to a carrier); protective immune response |
| 05/14/2009 | US20090123500 Active immunization using a siderophore receptor protein |
| 05/14/2009 | US20090123491 Novel method for preventing or treating M tuberculosis infection |
| 05/14/2009 | US20090123489 Novel immunotherapy against neuronal and brain tumors |
| 05/14/2009 | US20090123488 Compositions and methods for the treatment and prophylaxis of Alzheimer's disease |
| 05/14/2009 | US20090123486 Vaccine Composition Comprising An Antigen And A Peptide Having Adjuvant Properties |
| 05/14/2009 | US20090123485 Antigen Antibody Complexes as HIV-1 Vaccines |
| 05/14/2009 | US20090123479 Immunoglobulins |
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123467 Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious Disorders |
| 05/14/2009 | US20090123466 Anti-cd40 monoclonal antibody |
| 05/14/2009 | US20090123376 Therapeutic agents with decreased toxicity |
| 05/14/2009 | CA2705014A1 Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
| 05/14/2009 | CA2704853A1 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 05/14/2009 | CA2704663A1 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/14/2009 | CA2703099A1 Activin receptor-like kinase-i compositions and methods of use |
| 05/14/2009 | CA2702344A1 Analogues of glycolipids useful as immunoadjuvants |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058395A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058320A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 05/13/2009 | EP2058009A1 Reverse targeting lipid vesicle |
| 05/13/2009 | EP2057999A2 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 05/13/2009 | EP2057165A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 05/13/2009 | EP2057164A1 Triazolotriazines as kinase inhibitors |
| 05/13/2009 | EP2057158A1 Triazole derivatives as kinase inhibitors |
| 05/13/2009 | EP2057133A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 05/13/2009 | EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives |
| 05/13/2009 | EP2056880A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 05/13/2009 | EP2056867A2 Cystatin from nematodes in the treatment of autoimmune or allergic diseases |
| 05/13/2009 | EP2056861A2 Vaccine immunotherapy |
| 05/13/2009 | EP2056845A2 Structure and use of 5' phosphate oligonucleotides |
| 05/13/2009 | EP2056838A2 Combination therapy for treatment of immune disorders |
| 05/13/2009 | EP2056821A2 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders |
| 05/13/2009 | EP2056807A2 Treatment of inflammatory diseases |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1212405B1 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 05/13/2009 | EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 05/13/2009 | CN101432428A Recombinant human interferon-like proteins |
| 05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/13/2009 | CN101432298A PHL P1 allergen derivative |
| 05/13/2009 | CN101432023A Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| 05/13/2009 | CN101432000A Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101429483A Cultivation method for silkworm chrysalis cordyceps sinensis and capsule thereof |
| 05/13/2009 | CN101429185A Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429184A Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429164A Levorotation benzhydryl piperazidine derivant and preparing method thereof |
| 05/13/2009 | CN101428124A Plaster for strongly improving phylactic power and preparation method thereof |
| 05/13/2009 | CN101428067A Immunosuppressive agent and preparation method thereof |
| 05/13/2009 | CN101428057A Antimicrobial powder for reinforcing immune, strengthening the body resistance and removing toxicity for livestock and poultry |
| 05/13/2009 | CN101428049A Upper respiratory tract infection resistant medicament composition, preparation and uses thereof |
| 05/13/2009 | CN101428039A Educated nk t cells and their uses in the treatment of immune-related disorders |
| 05/13/2009 | CN101428033A Mix-configuration ginsenoside Rh2 and uses thereof |
| 05/13/2009 | CN100487064C Preparation process of squid ink black pigment and application thereof |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
| 05/13/2009 | CN100486983C Medicine compound for preventing diabets mellitus and preparing method thereof |
| 05/13/2009 | CN100486971C Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use |
| 05/13/2009 | CN100486596C Chinese medicine preparation with organism immunity increasing function |
| 05/13/2009 | CN100486595C Brazil mushroom soluble small molecular extract, its preparation technology and use |
| 05/13/2009 | CN100486593C Trachyostracous mussel extract capable of increasing immunity function |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486457C Pine-needle amino-acid oral liquid |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531651 e.g. 4-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]amino}methyl)benzamide benzenesulfonate dihydrate; chemokine (C-C motif) receptor antagonist; antiinflammatory agent; asthma, rhinitis |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531180 Chimeric alphavirus replicon particles |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | US7531168 Method for downmodulating immune response in type I diabetes |
| 05/12/2009 | CA2387398C Novel combination of loteprednol and antihistamines |
| 05/12/2009 | CA2386404C Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
| 05/12/2009 | CA2272338C Immunization of infants |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/12/2009 | CA2157864C Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/07/2009 | WO2009058361A1 Inhibition of type i ifn production |